Please reload

Recent Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

November 26, 2018

Please reload

Featured Posts

Frequency Therapeutics Welcome!

March 1, 2016

CreaGen Life Science Incubator team wishes a warm welcome to our new resident, Frequency Therapeutics! We are excited to have your team joining our incubator family.


Frequency Therapeutics is a platform technology that is based on discoveries in stem cell biology by Robert S. Langer at MIT and Jeff Karp at Harvard Medical School. Frequency Therapeutics initial focus is on chronic hearing loss, a potential $10B+ US market with no effective therapeutic solution. Other potential applications include gastrointestinal diseases and diabetes.



Please reload

Follow Us
Search By Tags